Search

everythinglearnresearchcommunity

for

Search:↓

Many female medical students in Saudi Arabia show signs of insulin resistance linked to increased waist size.

Balancing hormones is crucial for women's health and may require hormone therapy.

Balancing hormones can help women feel youthful and healthy.

Women with PCOS, especially with hirsutism, should be screened for depression and anxiety.

Women with hair loss have weaker hair that breaks more easily.

Women with PCOS have worse physical health but similar mental health compared to those without PCOS.

Women with certain types of hair loss may have low iron levels.

The document explains various skin conditions and their treatments.

Women with PCOS often have irregular periods, a higher chance of infertility and miscarriages, and may improve fertility with lifestyle changes and treatment.

A female runner's hair loss was caused by stress from surgery and recovery, but her hair returned to normal in 5 months.

About 30% of women feel they lose too much hair, often starting before age 40, and most can't find a reason for it.

Women with lupus experienced non-scarring hair loss with fewer hair follicles, and the test for lupus in hair was not helpful.

Women's acne improvement with antibiotics is not linked to signs of high male hormones.

Women with severe acne, hirsutism, and androgenic alopecia often have higher levels of certain androgens, but the specific pattern can't be predicted just by looking at symptoms.

Women with PCOS in Nigeria have higher heart risk markers, needing early heart health checks.

Women with PCOS risk had normal height and blood tests but higher weight and common acne or hirsutism.

Women with PCOS have higher 5alpha-reductase activity, affecting steroid levels.

Using 448-kHz Capacitive-Resistive Electrothermal Therapy can help increase hair density and prevent hair loss in women.

Spironolactone safely and effectively treats hair loss in female scarring alopecia patients.

Female pattern hair loss greatly affects quality of life, especially in younger patients, those with the condition for a long time, and those with mental health issues. A more comprehensive treatment approach is suggested.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Creating evidence-based guidelines for gender incongruence is difficult due to the personalized nature of transgender medicine.

Genetic mutations can affect female sexual development, requiring personalized medical care.

Collecting sexual orientation and gender identity data in dermatology can lead to better, more sensitive care for sexual and gender minority patients.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.